Establishing a TDT-specific reference range for FGF23 would aid in interpreting biochemical data and improving the understanding of the FGF23 role in thalassemia-associated endocrine complications, particularly thalassemic bone disease. The gene discussed is FGF23; the disease is thalassemia.